US 11672863
Enhanced solubility drug-containing formulations
granted A61KA61K31/445A61K47/02
Quick answer
US patent 11672863 (Enhanced solubility drug-containing formulations) held by United Therapeutics Corporation expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/445, A61K47/02, A61K47/12, A61K9/0019